AMRN today
$11.62-$0.09 (-0.77%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourBullish
15 minStrong Bullish
5 minSymmetric Triangle
Daily trend turns up above $24.60
Key levels
Resistance$12.57
Resistance$11.85
Support$11.34
Support$9.98
Latest news & SEC filings
NewsAmarin reports clinical findings on MACE risk markers at AHA 2026
EarningsAmarin Releases Q3 2026 Earnings
EarningsAmarin Corp holds Q3 2026 earnings call
SEC FilingAmarin Corp plc\Uk filed a report on a major company event (Form 8-K)
All AMRN news →About Amarin
Amarin is a pharmaceutical company that develops and sells cardiovascular therapies. Its main product, icosapent ethyl, is marketed as VASCEPA in America and VAZKEPA in Europe, and is approved to lower triglycerides and cut cardiovascular risk in selected high-risk adults. The company supplies wholesalers and pharmacies domestically and partners with other firms to commercialize the drug across Europe, Canada, the Middle East, Asia, Australia, New Zealand, and Israel.
Based on the company's 10-K filed Mar 2, 2026.
Nasdaq · Healthcare
AMARIN CORP PLC\UK (AMRN)
What Is the Price Target for AMRN?
SEPT Low Target
$13.00
SEPT Mid Target
$13.00
SEPT High Target
$13.00
Analyst Consensus
$13.00
Is AMRN a Buy or Sell Right Now?
Thesis
- •Revenue growing -6.5% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AMRN.
Start Free Trial →Is AMRN Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
Analyst Consensus
Fair Value
$13.00
39
Moat Score
NONE
5/9
Piotroski Score
11.6
Altman Z-Score
What Is Smart Money Doing with AMRN?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AMRN Growth Story
Revenue YoY
-6.5%
3yr Revenue CAGR
-16.7%
EPS Growth YoY
55%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for AMRN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AMRN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:57:28 | $11.69 | 1,200 | $$14K | BUY |
| 20:49:31 | $11.71 | 1,200 | $$14K | BUY |
| 19:51:39 | $11.70 | 1,100 | $$13K | BUY |
| 19:35:14 | $11.70 | 1,200 | $$14K | BUY |
| 19:21:18 | $11.70 | 1,200 | $$14K | BUY |
5 dark pool trades shown · $$69K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for AMARIN CORP PLC\UK (AMRN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AMRN — frequently asked questions
What is AMRN stock price today?
AMARIN CORP PLC\UK (AMRN) is at $11.62, down 0.77% (-$0.09) at the Nov 12, 2026 close.
Why is AMRN stock moving today?
Latest AMRN news — Nov 9, 2026: Amarin reports clinical findings on MACE risk markers at AHA 2026 · Oct 28, 2026: Amarin Releases Q3 2026 Earnings
What is the AMRN price target?
The average analyst price target for AMRN is $13.00, ranging from $13 to $13, based on 1 analysts.
What do analysts rate AMRN?
Analyst ratings for AMRN: 0 Buy, 0 Hold, 2 Sell — consensus Strong Sell.
Did AMRN beat earnings?
AMRN last reported on Oct 28, 2026: EPS $0.08 vs -$0.10 expected — a beat of 182.3%.
Does AMRN pay a dividend?
AMRN does not currently pay a dividend.
What are AMRN support and resistance levels?
Support: $11.34, $9.98, $9.44. Resistance: $11.85, $12.57, $13.18.
What are insiders doing with AMRN?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on AMRN?
Nov 9, 2026: Amarin reports clinical findings on MACE risk markers at AHA 2026 · Oct 28, 2026: Amarin Releases Q3 2026 Earnings · Oct 28, 2026: Amarin Corp holds Q3 2026 earnings call